What are the potential interactions between Abilify (aripiprazole) and fluticasone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interactions Between Aripiprazole and Fluticasone

There are no clinically significant pharmacokinetic interactions between aripiprazole and fluticasone, making them safe to use concurrently without dose adjustments. 1

Metabolism and Potential Interaction Pathways

  • Fluticasone is metabolized in the gastrointestinal tract and liver by CYP 3A4 isoenzymes, while aripiprazole is primarily metabolized through CYP 2D6 and CYP 3A4 pathways 1, 2
  • Aripiprazole has a mean elimination half-life of approximately 75 hours, reaching steady-state concentrations within 14 days of dosing 2
  • Neither medication significantly inhibits or induces the other's metabolic pathways at therapeutic doses, allowing for concurrent administration 1, 3

Safety Considerations

  • Fluticasone's systemic absorption is minimal when used as prescribed for allergic rhinitis, further reducing potential for systemic drug interactions 4
  • Potent CYP 3A4 inhibitors like ritonavir and ketoconazole can increase systemic concentrations of fluticasone, but aripiprazole is not considered a significant CYP 3A4 inhibitor 1
  • No reports of clinically significant Cushing syndrome or adrenal insufficiency have been documented when these medications are used together 1

Clinical Implications

  • Both medications can be administered according to their standard dosing guidelines without adjustments when used concurrently 1, 2
  • For fluticasone nasal spray in adults with allergic rhinitis, the recommended dose is 2 sprays per nostril once daily 4
  • For aripiprazole, the recommended starting and target dose is 10-15 mg/day administered once daily 2

Monitoring Recommendations

  • Monitor for potential neurological adverse effects of aripiprazole including insomnia, anxiety, and rarely neuroleptic malignant syndrome, especially in younger patients 5
  • When using intranasal fluticasone, be aware of potential local side effects such as nasal irritation and epistaxis, which are not affected by concurrent aripiprazole use 4
  • Allow 1-4 weeks for aripiprazole to reach full effect, and be aware that fluticasone's maximum efficacy for allergic rhinitis may take days to weeks 4, 2

Special Populations

  • In patients with bipolar disorder, the combination of aripiprazole with mood stabilizers has been shown to be effective with a relatively favorable side effect profile, and adding fluticasone would not be expected to alter this profile 6
  • For children and adolescents, careful monitoring is recommended as aripiprazole has been associated with adverse events including behavioral changes and weight gain in this population 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.